Evidence map›Paper›PMID 33786179›Full record

ReviewSAGE open medicine2021

Marijuana: A systems-based primer of adverse effects associated with use and an overview of its therapeutic utility.

Asim Kichloo, Michael Albosta, Michael Aljadah, Zain El-Amir, Ghazaleh Goldar, Muhammed Zatmar Khan, Dushyant Singh Dahiya, Srilakshmi Vallabhaneni, Farah Wani, Jagmeet Singh

Open access · goldAbstract readReview
In one paragraph

Review in SAGE open medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Cannabis-Induced Gastrointestinal Tract Symptoms in the Adult Population: A Systematic Review.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2024
    Pooled it
  2. Medical cannabis oil for benign essential blepharospasm: a prospective, randomized controlled pilot study.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2022
    Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Asim KichlooDepartment of Internal Medicine, Central Michigan University College of Medicine, Saginaw, MI, USA.
Michael AlbostaDepartment of Internal Medicine, Central Michigan University College of Medicine, Saginaw, MI, USA.ORCID https://orcid.org/0000-0003-4187-4911
Michael AljadahDepartment of Internal Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
Zain El-AmirDepartment of Internal Medicine, Central Michigan University College of Medicine, Saginaw, MI, USA.
Ghazaleh GoldarDepartment of Internal Medicine, Cleveland Clinic Foundation, Cleveland, OH, USA.
Muhammed Zatmar KhanDepartment of Internal Medicine, Central Michigan University College of Medicine, Saginaw, MI, USA.
Dushyant Singh DahiyaDepartment of Internal Medicine, Central Michigan University College of Medicine, Saginaw, MI, USA.
Srilakshmi VallabhaneniDepartment of Cardiology, St. Luke's University, Bethlehem, PA, USA.
Farah WaniDepartment of Family Medicine, Samaritan Medical Center, Watertown, NY, USA.
Jagmeet SinghDepartment of Nephrology, Guthrie Robert Packer Hospital, Sayre, PA, USA.
Central Michigan University · USCleveland Clinic · USGood Samaritan Medical Center · USMedical College of Wisconsin · USSt. Luke's University Health Network · USSUNY Upstate Medical University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Marijuana use is on the rise in the United States. By the end of 2019, 33 states have legalized marijuana use and marijuana byproduct use for medical purposes. However, marijuana use does not come without side effects. This manuscript reviews the increasing usage of marijuana and the different forms (natural and synthetic) that patients may use when presenting to clinicians. It also addresses the biochemical and behavioral changes observed with marijuana use, including the location and changes associated with cannabinoid receptors (abbreviated CB1 and CB2). These two topics lead into an extensive review of the side effects of marijuana use. This manuscript discusses gastrointestinal side-effects, such as Cannabinoid Hyperemesis Syndrome, pancreatitis, and hepatotoxicity. It also briefly reviews cardiovascular, neurologic, and pulmonary side effects. This article provides an overview of therapeutic effects of marijuana including the antiemetic effect, its medical utility as an appetite stimulant, and usefulness in cancer patients post-chemotherapy. A thorough social history pertaining to marijuana use is an important consideration for clinicians in patients presenting with a variety of symptoms, including those effecting the gastrointestinal, cardiovascular, pulmonary, or neurologic systems.

Indexed as

cannabisEpidemiology/public healthgastroenterology/hepatologypharmacoepidemiology/drug safetyside effects

Identifiers

PMID33786179
PMCPMC7958160
OpenAlexW3134270738

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.